Daré Bioscience, Inc.

DARE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $7.6M $44.6K $219.4K $51.2M $5.5M
Accounts Receivable — — — — —
Inventory — — — — —
Total Current Assets $8.3M $44.6K $77.3M $52.8M $6.4M
Property, Plant & Equipment $0 $668.0K $576.0K $342.0K $245.0K
Goodwill $5.2M — — — —
Intangible Assets (Excl. Goodwill) — — — — —
Total Assets $14.3M $44.6K $78.2M $53.4M $6.8M
Liabilities
Accounts Payable $308.2K $1.4M $2.2M $1.3M $914.0K
Total Current Liabilities $966.7K $755.2K $16.3M $8.1M $15.1M
Long-Term Debt — — — — —
Total Liabilities $967.0K $755.2K $78.3M $8.1M $101.1M
Stockholders' Equity
Retained Earnings $-12.2M $-727.8K $-161.4M $-121.8M $-98.4M
Total Stockholders' Equity $13.3M $-710.6K $-46.9K $45.3M $-94.3M
← Newer Page 2 of 2 Older →